On Dec. 16, 2025, researchers from the International Vaccines Access Center (IVAC) reported that as of mid-December, flu,…
On Dec. 9, 2025, officials from the Canada Economic Development for Quebec Regions, and the Minister of Industry,…
On Nov. 10, 2025, Canada has lost its measles elimination status after nearly three decades due to its…
On Oct. 2, 2025, researchers in McGill’s Department of Physics announced they have developed a new device that can trap…
On Apr. 15, 2025, Moderna announced that its manufacturing facility in Harwell, Oxfordshire, the Moderna Innovation and Technology…
On Mar. 24, 2025, scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto…
On Dec. 11, 2024 the Board of Directors of AquaBounty Technologies announced that the Company was winding down…
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
On Mar. 23, 2023, a study published in Scientific Reports warned that vibrio vulnificus is an increasingly recognized…
On Mar. 17, 2023, PrairiesCan announced $80,514,000 over five years to support the Canadian Critical Drug Initiative and…
On Feb. 17, 2023, Moderna announced that Health Canada had authorized the use of its Omicron-targeting bivalent COVID-19…
On Feb. 14, 2023, the Pacific Economic Development Agency of Canada (PacifiCan), announced $14.5 million in funding for…
On Nov. 3, 2022, Health Canada authorized an adapted version of the Moderna Spikevax COVID-19 vaccine that targets…
On Apr. 12, 2022, the Province of Alberta poultry reported that farms had tested positive for highly pathogenic…
On Mar. 17, 2022, Moderna announced that Health Canada had approved the use of Moderna’s mRNA COVID-19 vaccine,…
On Dec. 21, 2021, the United States Department of Agriculture’s (USDA) National Veterinary Services Laboratories announced confirmation of…
On Jun. 22, 2021, the National Research Council of Canada (NRC) announced it had completed construction of the…
On Apr. 19, 2021, CytoDyn announced it had submitted the manufacturing section (CMC) of the application for an…
On Mar. 17, 2021, Altasciences working with the National Research Council of Canada (NRC), announced that it had…
On Jan. 28, 2021, OraSure Technologies announced its OMNIgene®·ORAL (OME-505) saliva collection device, a product of Ottawa-based subsidiary…
On Dec. 18, 2020, the National Research Council of Canada (NRC) announced it was providing advisory services and…
On Dec. 15, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
On Apr. 6, 2020, 3M and the White House announced a plan to import 166.5 million respirators over…
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…
On Mar. 26, 2020, the US Food and Drug Administration (FDA) granted expanded emergency use authorisation (EUA) for…
On Mar. 25, 2020, University of Oxford researchers announced they had launched the world’s first COVID-19 government response…
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
On Feb. 25, 2020, a University of British Columbia (UBC) researcher was part of an international team working…